医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
(9CI)-5-氟-2-甲基喹啉 | 5-fluoroquinaldine | 346604-38-4 | C10H8FN |
|
(9CI)-4-乙基-2-甲基嘧啶 | 4-ethyl-2-methylpyrimidine | 65845-70-7 | C7H10N2 |
|
(9CI)-4-(苯基甲基)-嘧啶 | 4-benzylpyrimidine | 64660-82-8 | C11H10N2 |
|
(9CI)-4-(4-吡啶)-嘧啶 | 4-(4-pyridyl)pyrimidine | 53345-78-1 | C9H7N3 |
|
(9CI)-3-(氯甲基)-喹啉 | 3-(chloromethyl)-quinoline | 104325-51-1 | C10H8ClN |
|
(9CI)-3,5-二氟吡啶 1-氧化物 | 3,5-difluoro(pyridine 1-oxide) | 210169-07-6 | C5H3F2NO |
|
(9CI)-3,4-双(氯甲基)-吡啶 | 3,4-Bis(chloromethyl)pyridine | 38070-81-4 | C7H7Cl2N |
|
(9CI)-2-氯-4-乙炔嘧啶 | 2-chloro-4-ethynylpyrimidine | 37968-69-7 | C6H3ClN2 |
|
(9-苯基-9H-咔唑-2-基)硼酸 | (9-phenyl-9H-carbazol-2-yl)boronic acid | 1001911-63-2 | C18H14BNO2 |
|
(8aS)-8a-甲基-八氢吡咯并[1,2-a]哌嗪 | (S)-8a-methyloctahydropyrrolo[1,2-a]pyrazine | 1261569-85-0 | C8H16N2 |
|
(8S,10S,13S,14S,17R)-17-乙酰基-17-羟基-10,13-二甲基-2,6,7,8,12,14,15,16-八氢-1H-环戊二烯并[a]菲-3-酮 | 17α-hydroxypregna-4,9(11)-diene-3,20-dione | 34184-82-2 | C21H28O3 |
|
(8S)-5,6,7,8-四氢-8-氨基喹啉 | (S)-5,6,7,8-tetrahydroquinolin-8-amine | 369656-57-5 | C9H12N2 |
|
(8R)-5,6,7,8-四氢-8-氨基喹啉 | (R)-(-)-8-amino-5,6,7,8-tetrahydroquinoline | 369655-84-5 | C9H12N2 |
|
(8E,10E)-8,10-十二碳二烯-1-醇乙酸酯 | (E,E)-8,10-dodecadienyl acetate | 53880-51-6 | C14H24O2 |
|
(8CI,9CI)-四甲基嘧啶 | 2,4,5,6-Tetramethylpyrimidine | 22868-80-0 | C8H12N2 |
|
(8CI,9CI)-2-(1H-四唑-5-基)-嘧啶 | 2-(1H-tetrazol-5-yl)pyrimidine | 13600-33-4 | C5H4N6 |
|
(8CI)-5-戊基嘧啶 | 5-n-Amylpyrimidin | 33115-34-3 | C9H14N2 |
|
(8CI)-5-丁基嘧啶 | 5-butylpyrimidine | 33115-33-2 | C8H12N2 |
|
(8CI)-4-氨基-2-(乙氧基甲基)-嘧啶 | 4-amino-2-(methoxymethyl)pyrimidine | 3122-85-8 | C6H9N3O |
|
(7ci,9ci)-5-嘧啶羰酰氯 | pyrimidine-5-carbonyl chloride | 40929-48-4 | C5H3ClN2O |
|
(7alpha,17beta)-17-(乙酰氧基)-7-[9-[(4,4,5,5,5-五氟戊基)硫代]壬基]雌甾-4-烯-3-酮 | (7α,17β)-3-oxo-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfanyl]nonyl}estr-4-en-17-yl acetate | 415927-29-6 | C34H51F5O3S |
|
(7a,17b)- 7-[9-[(4,4,5,5,5-五氟戊基)硫]壬基]雌甾-1,3,5(10)-三烯-3,17-二醇 17-醋酸酯 | 17-O-acetyl-S-deoxo-fulvestrant | 875573-69-6 | C34H49F5O3S |
|
(7a,17b)- 7-[9-[(4,4,5,5,5-五氟戊基)硫]壬基]雌甾-1,3,5(10)-三烯-3,17-二醇 | ICI 182,780 | 153004-31-0 | C32H47F5O2S |
|
(7a,17b)- 7-(9-溴壬基)雌甾-1,3,5(10)-三烯-3,17-二醇 17-醋酸酯 | (+)-(7α)-[9-bromononyl]estra-1,3,5(10)-triene-3-ol-17β-yl acetate | 875573-66-3 | C29H43BrO3 |
|
(7S)-6,7-二氢-5H-环戊并[b]吡啶-7-醇 | (S)-6,7-dihydro-5H-[1]pyrindin-7-ol | 887921-99-5 | C8H9NO |
|
(7S)-6,7-二氢-5H-环戊并[b]吡啶-7-胺 | (S)-5H,6H,7H-cyclopenta[b]pyridin-7-amine | 502612-54-6 | C8H10N2 |
|
(7S)-5-氮杂螺[2.4]庚烷-7-基氨基甲酸叔丁酯 | tert-butyl (S)-(5-azaspiro[2.4]heptan-7-yl)carbamate | 127199-45-5 | C11H20N2O2 |
|
(7CI,8CI,9CI)-2,4-二氟-6-甲基嘧啶 | 2,4-difluoro-6-methyl-pyrimidine | 696-80-0 | C5H4F2N2 |
|
(7CI,8CI)-5-氟-2-(甲基硫代)-嘧啶 | 5-fluoro-2-(methylthio)pyrimidine | 6090-37-5 | C5H5FN2S |
|
(7-碘[1,2,4]三氮唑并[1,5-A]吡啶) | 7-iodo-[1,2,4]triazolo[1,5-a]pyridine | 690258-25-4 | C6H4IN3 |
|
(7-溴庚基)氨基甲酸叔丁酯 | tert-butyl (7-bromoheptyl)carbamate | 142356-34-1 | C12H24BrNO2 |
|
(7-溴喹啉-4-基)丙胺 | 3-(7-Bromoquinolin-4-yl)propan-1-amine | 71595-18-1 | C12H13BrN2 |
|
(7-溴-1-乙基-1H-咪唑并[4,5-c]吡啶-2-基)乙腈 | 2-(7-bromo-1-ethylimidazo[4,5-c]pyridin-2-yl)acetonitrile | 842143-97-9 | C10H9BrN4 |
|
(6ci,7ci,8ci,9ci)-1-乙酰基-1H-1,2,4-噻唑 | 1-acetyl-1<i>H</i>-[1,2,4]triazole | 15625-88-4 | C4H5N3O |
|
(6S)4,6,7,8-四氢-4-氧代吡咯并[1,2-A]嘧啶-6-羧酸 | (S)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylic acid | 1190392-22-3 | C8H8N2O3 |
|
(6S)-5-氮杂螺[2.4]庚烷-5,6-二甲酸 5-叔丁酯 钾盐 | (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylate | 1441673-92-2 | C12H18NO4*K |
|
(6R-反式)-3-(羟基甲基)-8-氧代-7-(2-噻吩基乙酰氨基)-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸 | deacetylcephalothin | 5935-65-9 | C14H14N2O5S2 |
|
(6R-反式)-3-(乙酰氧基甲基)-7-[(2-氨基噻唑-4-基)乙酰氨基]-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸 | 7β-[2-(2-aminothiazol-4-yl)acetylamino]-3-acetoxymethyl-3-cephem-4-carboxylic acid | 58233-18-4 | C15H16N4O6S2 |
|
(6E)-6-[(2E,4E,6E)-3,7-二甲基壬-2,4,6,8-四烯亚基]-1,5,5-三甲基环己烯 | Anhydro-retinol | 1224-78-8 | C20H28 |
|
(6CI,9CI)-2-甲基-3-吡啶乙腈 | (2-methylpyridin-3-yl)acetonitrile | 101166-73-8 | C8H8N2 |
|
(6CI,8CI,9CI)-5-乙基嘧啶 | 5-Ethylpyrimidine | 25193-94-6 | C6H8N2 |
|
(6CI)-4-丁基-6-甲基嘧啶 | 4-butyl-6-methyl-pyrimidine | 114425-76-2 | C9H14N2 |
|
(6-甲酰基吡啶-3-基)三氟硼酸钾 | potassium (6-formylpyridin-3-yl)trifluoroborate | 1245906-61-9 | C6H4BF3NO*K |
|
(6-甲酰基吡啶-2-基)氨基甲酸叔丁酯 | tert-butyl (6-formylpyridin-2-yl)carbamate | 956523-98-1 | C11H14N2O3 |
|
(6-甲氧基吡啶-3-基)甲基胺 | (6-methoxypyridin-3-yl)methanamine | 262295-96-5 | C7H10N2O |
|
(6-甲基哌啶-3-基)甲醇 | (6-methylpiperidin-3-yl)methanol | 278789-37-0 | C7H15NO |
|
(6-甲基吡啶-2-基)甲基乙酸酯 | 2-acetoxymethyl-6-methylpyridine | 13287-64-4 | C9H11NO2 |
|
(6-溴咪唑并[1,2-a]吡啶-3-基)苯基甲酮 | (6-bromoimidazo[1,2-a]pyridin-3-yl)(phenyl)methanone | 1284293-40-8 | C14H9BrN2O |
|
(6-溴咪唑并[1,2-a]吡啶-2-基)甲醇 | (6-bromoimidazo[1,2-a]pyridin-2-yl)-methanol | 136117-71-0 | C8H7BrN2O |
|
(6-溴吡啶-2-基)乙腈 | 2-(6-bromopyridin-2-yl)acetonitrile | 112575-11-8 | C7H5BrN2 |
|